1351762-51-0

Basic information

• Product Name: N-[4-(3-chlorobenzyloxy)phenyl]-4-methylbenzenesulfonamide
• CAS NO: 1351762-51-0
• Molecular Weight: 387.887
• Mol File: 1351762-51-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[4-(3-chlorobenzyloxy)phenyl]-4-methylbenzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[4-(3-chlorobenzyloxy)phenyl]-4-methylbenzenesulfonamide(1351762-51-0)
• EPA Substance Registry System: N-[4-(3-chlorobenzyloxy)phenyl]-4-methylbenzenesulfonamide(1351762-51-0)

Safety Data

• Hazardous Substances Data: 1351762-51-0(Hazardous Substances Data)

Upstream product

• 1146-43-6 N-(4-hydroxyphenyl)-4-methylbenzenesulfonamide 
• 766-80-3 1-bromomethyl-3-chlorobenzene 

Relevant articles and documents

Design, synthesis, and biological evaluation of sulfonic acid ester and benzenesulfonamide derivatives as potential CETP inhibitors

Epidemiological studies have established an inverse relationship between plasma high-density lipoprotein (HDL) cholesterol concentration, and incidence of coronary artery disease (CAD); thus, the development of novel therapies that attempt to exploit the atheroprotective functions of HDL is a major goal. Inhibition of cholesteryl ester transfer protein (CETP) is one of the approaches targeted to increase HDL cholesterol concentration. CETP is a glycoprotein involved in transporting lipoprotein particles and neutral lipids between HDL and low-density lipoproteins (LDL), and therefore CETP inhibitors could be useful agents in the future for treating dyslipidemia and related disorders. Guided by our previously reported pharmacophore and QSAR models for CETP inhibition, we synthesized and bioassayed a series of sulfonic acid ester and benzenesulfonamide derivatives that can serve as a promising lead compounds for the development of potential and selective CETP inhibitors. The most potent compound 6k illustrated an IC50 of 3.4 lM. Springer Science+Business Media, LLC 2011.